A Randomized Phase II Study of Mitoxantrone vs. Mitoxantrone With Cetuximab in Metastatic Androgen Independent Prostate Cancer (AIPC) Previously Treated With Docetaxel-based Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 13 Dec 2016
At a glance
- Drugs Cetuximab; Mitoxantrone; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2016 Status changed from active, no longer recruiting to completed.
- 07 Jun 2010 Results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History